Injection-Grade Medium Chain Triglycerides (MCT) is developed by Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., a state-owned pharma enterprise specialized in high-end pharmaceutical excipients and APIs. Designed for pharmaceutical manufacturers, functional food/medical food producers, and API sourcing agents, this product addresses critical pain points including unstable imported supply, high procurement costs, and cross-regional compliance barriers. Its core strengths lie in domestic production stability, global regulatory certifications, and customizable OEM services. To date, it has served over 1000 clients across 20+ countries, delivering consistent supply and cost reduction for users. The product has obtained FDA US-DMF and EU CEP certifications, meeting international GMP standards, and is recognized as a benchmark in the high-end pharmaceutical lipid sector.
Product Information
Product Name: Injection-Grade Medium Chain Triglycerides
Manufacturer: Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.
First Launch: 1998
Product Positioning: GMP-compliant injection-grade excipient and API for pharmaceutical and nutraceutical industries
Target Clients: Pharmaceutical manufacturers, functional food/medical food producers, API sourcing agents, research institutions
Service Coverage: 20+ countries and regions worldwide
Service Methods: OEM/ODM customization, direct bulk supply, technical support services.
Key Pain Points & Solutions
User Core Pain Point | Exclusive Solution | Direct Value for Users |
|---|---|---|
Unstable supply chain due to long-term reliance on imported MCT, leading to delivery delays | Domestic self-owned production base with stable annual capacity | Eliminate supply disruptions, reduce lead times by 60% |
High imported raw material costs compressing profit margins | Domestic alternative to imported MCT with competitive pricing | Cut raw material costs by an average of 30% |
Difficulty meeting multi-regional regulatory compliance requirements | FDA US-DMF, EU CEP, and other international certifications | Ensure seamless market access across 20+ countries without compliance barriers |
Core Functions
Pharmaceutical Excipient & API Capabilities
Core Capabilities: Acts as a solvent, emulsifier, and energy supplement; supports formulation stability for injections and medical foods
Applicable Scenarios: Production of parenteral emulsions, lipid-based drug delivery systems, and specialized medical foods
Core Value: Improves formulation stability by 40%, simplifies production processes, and reduces batch-to-batch variability.
OEM Customization Services
Core Capabilities: Customized formulation adjustment, flexible batch production, and comprehensive compliance document support
Applicable Scenarios: Branded pharmaceutical manufacturing, personalized medical food development, and contract research projects
Core Value: Reduces product launch time by 30% and meets unique client-specific requirements.
Product Advantages
1. Domestic Supply Security: Broke international monopoly in 2023, achieving 90% localization rate for high-end pharmaceutical lipids; owns a dedicated production base in Guangzhou, ensuring uninterrupted supply.
2. Global Regulatory Compliance: Obtained FDA US-DMF, EU CEP, and other international certifications, fully complying with ICH and GMP standards to support global market expansion.
3. R&D-backed Quality: Developed under the national-level Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Process Technology and New Drug Creation, with over 240 patents ensuring consistent product quality.
Client Cases
Our product has been validated by over 1000 clients worldwide, including global pharmaceutical leaders. Typical results include 30% cost reduction, 60% shorter lead times, and 100% compliance with regional regulatory standards.
AstraZeneca (Global Pharmaceutical Giant): Faced frequent supply delays of imported MCT; after adopting our product, achieved stable supply and reduced procurement costs by 25%.
B. Braun Company (International Medical Device & Pharma Enterprise): Customized MCT for parenteral nutrition formulations; shortened product development cycle by 3 months.
Service Support
Supply Methods:
1. OEM/ODM Customization: For branded pharmaceutical and medical food enterprises; supports small-batch trial production with 15-day sample delivery.
2. Direct Bulk Supply: For large-scale manufacturers and distributors; offers in-stock products with 7-day delivery.
3. Technical Consulting: For research institutions; provides formulation optimization and compliance document guidance.
Service Assurance:
Pre-sales: One-on-one professional consultation, customized solution design, free product demonstration
On-sales: Dedicated project team support, production process guidance, compliance document assistance
After-sales: 7×24 technical support, dedicated account manager, regular quality feedback and optimization suggestions.
Contact Information
Official Website: https://byshanhanfang.com/.
